Abstract
Prevention of post-ERCP pancreatitis: where are we now?
Highlights
Endoscopic Retrograde Cholangio Pancreaticography (ERCP) is used worldwide and is a first line therapeutic procedure to manage a range of pancreatic and biliary disorders
There are a large number of interventions than have been employed to decrease this risk. In this mini-review, we summarise measures that can be used to decrease the risk of post Endoscopic Retrograde Cholangio-Pancreatography (ERCP) pancreatitis
The low cost of Non-Steroidal AntiInflammatory Drugs (NSAIDs), ease of use, the growing body of evidence and safety profile contribute to the recommendation by the American Society of Gastrointestinal Endoscopy (ASGE) and the European Society of Gastrointestinal Endoscopy (ESGE) that rectal NSAIDs should be given peri-procedure in all without contraindication
Summary
Received: Apr 08, 2018 Accepted: Jun 15, 2018 Published Online: Jun 22, 2018 Journal: Annals of Gastroenterology and the Digestive System Publisher: MedDocs Publishers LLC Online edition: http://meddocsonline.org/ Copyright: © Colleypriest B (2018).
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
